Survival rates rise in studies of Edwards, CoreValve heart valves
Tuesday, October 14, 2008 - 02:21
in Health & Medicine
Edwards Lifesciences Corp.'s minimally invasive heart valve kept 94% of patients alive a month after surgery, the best results yet for a technology that may grow into a $1.3-billion market for medical device makers.